Physiology and Regulation of the Renin-Angiotensin-Aldosterone System

Textbook of Nephro-Endocrinology

Volumn , Issue , 2009, Pages 147-165

  Carey, Robert M ^a   Padia, Shetal H ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882528610     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-373870-7.00012-0     Document Type: Chapter

References (153)

1. Adamczak M., Zeier M., Dikow R., Ritz E. Kidney and hypertension. Kidney Int Sup 2002, 62-67.
2. Agoudemos M.M., Greene A.S. Localization of the renin-angiotensin system components to the skeletal muscle microcirculation. Microcirculation 2005, 12:627-636.
3. Allen A. Localization and function of angiotensin AT1 receptors. Am J Hypertens 2000, 13:31S-38S.
4. Berman L.B., Vertes V., Mitra S., Gould A.B. Renin-angiotensin system in anephric patients. N Engl J Med 1972, 286:58-61.
5. Boddi M., Poggesi L., Coppo M., et al. Human vascular renin-angiotensin system and its functional changes in relation to different sodium intakes. Hypertension 1998, 31:836-842.
6. Brilla C.G., Weber K.T. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat. Cardiovasc Res 1992, 26:671-677.
7. Brilla C.G., Matsubara L.S., Weber K.T. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism. J Mol Cell Cardiol 1993, 25:563-575.
8. Campbell D.J., Kladis A., Duncan A.M. Nephrectomy, converting enzyme inhibition, and angiotensin peptides. Hypertension 1993, 22:513-522.
9. Carey R.M., Siragy H.M. Newly recognized components of the renin-angiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 2003, 24:261-271.
10. Cervenka L., Wang C.T., Mitchell K.D., Navar L.G. Proximal tubular angiotensin II levels and renal functional responses to AT1 receptor blockade in nonclipped kidneys of Goldblatt hypertensive rats. Hypertension 1999, 33:102-107.
11. Chai W., Danser A.H. Is angiotensin II made inside or outside of the cell? Curr Hypertens Rep 2005, 7:124-127.
12. Chappell M.C., Allred A.J., Ferrario C.M. Pathways of angiotensin-(1-7) metabolism in the kidney. Nephrol Dial Transplant 2001, 16(Suppl 1):22-26.
13. Chen R., Mukhin Y.V., Garnovskaya M.N., et al. A functional angiotensin II receptor-GFP fusion protein: evidence for agonist-dependent nuclear translocation. Am J Physiol Renal Physiol 2000, 279:F440-F448.
14. Crackower M.A., Sarao R., Oudit G.Y., et al. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002, 417:822-828.
15. Crowley S.D., Gurley S.B., Oliverio M.I., et al. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest 2005, 115:1092-1099.
16. Crowley S.D., Gurley S.B., Herrera M.J., et al. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci USA 2006, 103:17985-17990.
17. Danser A.H. Local renin-angiotensin systems. Mol Cell Biochem 1996, 157:211-216.
18. Danser A.H., van Kats J.P., Admiraal P.J., et al. Cardiac renin and angiotensins. Uptake from plasma versus in situ synthesis. Hypertension 1994, 24:37-48.
19. de Gasparo M., Catt K.J., Inagami T., Wright J.W., Unger T. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 2000, 52:415-472.
20. Diz D.I., Chappell M.C., Tallant E.A., Ferrario C.M. Angiotensin (1-7). Hypertension 2005, 100-110.
21. Dluhy R.G., Williams G.H. Aldosterone - villain or bystander?. N Engl J Med 2004, 351:8-10.
22. Dostal D.E. The cardiac renin-angiotensin system: novel signaling mechanisms related to cardiac growth and function. Regul Pept 2000, 91:1-11.
23. Dostal D.E., Baker K.M. The cardiac renin-angiotensin system: conceptual, or a regulator of cardiac function?. Circ Res 1999, 85:643-650.
24. Dzau V.J., Re R.N. Evidence for the existence of renin in the heart. Circulation 1987, 75:I134-I136.
25. Erdos, E.G., and Skidgel, R.A. (1997). Metabolism of bradykinin by peptidases in health and diesease. In Farmer S.C. (ed.). The Kinin system: handbook of immunopharmology. pp. 112-41.
26. Erdos E.G., Marcic B.M. Kinins, receptors, kininases and inhibitors - where did they lead us?. Biol Chem 2001, 382:43-47.
27. Everett A.D., Carey R.M., Chevalier R.L., Peach M.J., Gomez R.A. Renin release and gene expression in intact rat kidney microvessels and single cells. J Clin Invest 1990, 86:169-175.
28. Ferrario C.M., Chappell M.C. Novel angiotensin peptides. Cell Mol Life Sci 2004, 61:2720-2727.
29. Fournie-Zaluski M.C., Fassot C., Valentin B., et al. Brain renin-angiotensin system blockade by systemically active aminopeptidase A inhibitors: a potential treatment of salt-dependent hypertension. Proc Natl Acad Sci USA 2004, 101:7775-7780.
30. Frohlich E.D. Arthus C. Corcoran Memorial Lecture. Influence of nitric oxide and angiotensin II on renal involvement in hypertension. Hypertension 1997, 29:188-193.
31. Funder J.W. Cardiac synthesis of aldosterone: going, going, gone?. Endocrinology 2004, 145:4793-4795.
32. Funder J.W. Why are mineralocorticoid receptors so non-selective?. Curr Hypertens Rep 2007, 9:112-116.
33. Funder J.W., Feldman D., Edelman I.S. The roles of plasma binding and receptor specificity in the mineralocorticoid action of aldosterone. Endocrinology 1973, 92:994-1004.
34. Funder J.W., Pearce P.T., Smith R., Campbell J. Vascular type I aldosterone binding sites are physiological mineralocorticoid receptors. Endocrinology 1989, 125:2224-2226.
35. Funder J.W., Pearce P.T., Smith R., Smith A.I. Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 1988, 242:583-585.
36. Giasson E., Servant M.J., Meloche S. Cyclic AMP-mediated inhibition of angiotensin II-induced protein synthesis is associated with suppression of tyrosine phosphorylation signaling in vascular smooth muscle cells. J Biol Chem 1997, 272:26879-26886.
37. Gomez R.A., Lynch K.R., Chevalier R.L., et al. Renin and angiotensinogen gene expression and intrarenal renin distribution during ACE inhibition. Am J Physiol 1988, 254:F900-F906.
38. Gomez R.A., Lynch K.R., Sturgill B.C., et al. Distribution of renin mRNA and its protein in the developing kidney. Am J Physiol 1989, 257:F850-F858.
39. Gomez R.A., Chevalier R.L., Everett A.D., et al. Recruitment of renin gene-expressing cells in adult rat kidneys. Am J Physiol 1990, 259:F660-F665.
40. Gomez-Sanchez C.E., Zhou M.Y., Cozza E.N., Morita H., Foecking M.F., Gomez-Sanchez E.P. Aldosterone biosynthesis in the rat brain. Endocrinology 1997, 138:3369-3373.
41. Gomez-Sanchez E.P., Ahmad N., Romero D.G., Gomez-Sanchez C.E. Origin of aldosterone in the rat heart. Endocrinology 2004, 145:4796-4802.
42. Gordon R.D., Laragh J.H., Funder J.W. Low renin hypertensive states: perspectives, unsolved problems, future research. Trends Endocrinol Metab 2005, 16:108-113.
43. Griendling K.K., Murphy T.J., Alexander R.W. Molecular biology of the renin-angiotensin system. Circulation 1993, 87:1816-1828.
44. Haller H., Lindschau C., Erdmann B., Quass P., Luft F.C. Effects of intracellular angiotensin II in vascular smooth muscle cells. Circ Res 1996, 79:765-772.
45. Harrison-Bernard L.M., Navar L.G., Ho M.M., Vinson G.P., el-Dahr S.S. Immunohistochemical localization of ANG II AT1 receptor in adult rat kidney using a monoclonal antibody. Am J Physiol 1997, 273:F170-F177.
46. Hilgers K.F., Veelken R., Muller D.N., et al. Renin uptake by the endothelium mediates vascular angiotensin formation. Hypertension 2001, 38:243-248.
47. Hsueh W.A., Baxter J.D. Human prorenin. Hypertension 1991, 17:469-477.
48. Inada Y., Wada T., Ojima M., et al. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 1997, 19:1079-1099.
49. Ingert C., Grima M., Coquard C., Barthelmebs M., Imbs J.L. Contribution of angiotensin II internalization to intrarenal angiotensin II levels in rats. Am J Physiol Renal Physiol 2002, 283:F1003-F1010.
50. Ishida M., Ishida T., Thomas S.M., Berk B.C. Activation of extracellular signal-regulated kinases (ERK1/2) by angiotensin II is dependent on c-Src in vascular smooth muscle cells. Circ Res 1998, 82:7-12.
51. Joffe H.V., Adler G.K. Effect of aldosterone and mineralocorticoid receptor blockade on vascular inflammation. Heart Fail Rev 2005, 10:31-37.
52. Kimbrough H.M., Vaughan E.D., Carey R.M., Ayers C.R. Effect of intrarenal angiotensin II blockade on renal function in conscious dogs. Circ Res 1977, 40:174-178.
53. Kobori H., Prieto-Carrasquero M.C., Ozawa Y., Navar L.G. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 2004, 43:1126-1132.
54. Kobori H., Harrison-Bernard L.M., Navar L.G. Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension. Hypertension 2001, 37:1329-1335.
55. Kobori H., Harrison-Bernard L.M., Navar L.G. Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 2001, 12:431-439.
56. Kobori H., Nishiyama A., Harrison-Bernard L.M., Navar L.G. Urinary angiotensinogen as an indicator of intrarenal angiotensin status in hypertension. Hypertension 2003, 41:42-49.
57. Komlosi P., Fuson A.L., Fintha A., et al. Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport. Hypertension 2003, 42:195-199.
58. Laragh J. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Am J Hypertens 2001, 14:837-854.
59. Lavoie J.L., Cassell M.D., Gross K.W., Sigmund C.D. Localization of renin expressing cells in the brain, by use of a REN-eGFP transgenic model. Physiol Genomics 2004, 16:240-246.
60. Lavoie J.L., Cassell M.D., Gross K.W., Sigmund C.D. Adjacent expression of renin and angiotensinogen in the rostral ventrolateral medulla using a dual-reporter transgenic model. Hypertension 2004, 43:1116-1119.
61. Levens N.R., Freedlender A.E., Peach M.J., Carey R.M. Control of renal function by intrarenal angiotensin II. Endocrinology 1983, 112:43-49.
62. Lijnen P., Petrov V. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J Mol Cell Cardiol 1999, 31:949-970.
63. Linderman J.R., Greene A.S. Distribution of angiotensin II receptor expression in the microcirculation of striated muscle. Microcirculation 2001, 8:275-281.
64. Linz W., Wiemer G., Gohlke P., Unger T., Scholkens B.A. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 1995, 47:25-49.
65. Lochard N., Thibault G., Silversides D.W., Touyz R.M., Reudelhuber T.L. Chronic production of angiotensin IV in the brain leads to hypertension that is reversible with an angiotensin II AT1 receptor antagonist. Circ Res 2004, 94:1451-1457.
66. Matsubara H., Sugaya T., Murasawa S., et al. Tissue-specific expression of human angiotensin II AT1 and AT2 receptors and cellular localization of subtype mRNAs in adult human renal cortex using in situ hybridization. Nephron 1998, 80:25-34.
67. Mitchell, K.D. and Navar, L.G. (1995). Intrarenal actions of angiotensin II in the pathogenesis of experimental hypertension. In Hypertension: pathophysiology, diagnosis and management, (Laragh, J.H., Brenner, B.M., eds). Lippincott, Williams and Wilkins, Philadelphia, PA, pp. 1437-1450.
68. Miyata N., Park F., Li X.F., Cowley A.W. Distribution of angiotensin AT1 and AT2 receptor subtypes in the rat kidney. Am J Physiol 1999, 277:F437-F446.
69. Moulik S., Speth R.C., Turner B.B., Rowe B.P. Angiotensin II receptor subtype distribution in the rabbit brain. Exp Brain Res 2002, 142:275-283.
70. Murphy T.J., Alexander R.W., Griendling K.K., Runge M.S., Bernstein K.E. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 1991, 351:233-236.
71. Navar, L., and Ham, L.L. (1999). The kidney in blood pressure regulation. In Wilcox, CS, ed. Atlas of Diseases of the Kidney, 1.1-1.2.
72. Navar L.G. The kidney in blood pressure regulation and development of hypertension. Med Clin North Am. 1997, 81:1165-1198.
73. Navar L.G., Harrison-Bernard L.M., Nishiyama A., Kobori H. Regulation of intrarenal angiotensin II in hypertension. Hypertension 2002, 39:316-322.
74. Navar L.G., Kobori H., Prieto-Carrasquero M. Intrarenal angiotensin II and hypertension. Curr Hypertens Rep 2003, 5:135-143.
75. Nguyen G., Delarue F., Berrou J., Rondeau E., Sraer J.D. Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigen. Kidney Int 1996, 50:1897-1903.
76. Nguyen G., Bouzhir L., Delarue F., Rondeau E., Sraer J.D. Evidence of a renin receptor on human mesangial cells: effects on PAI1 and cGMP. Nephrologie 1998, 19:411-416.
77. Nguyen G., Delarue F., Burckle C., Bouzhir L., Giller T., Sraer J.D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest 2002, 109:1417-1427.
78. Nishiyama A., Seth D.M., Navar L.G. Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 2002, 39:129-134.
79. Nishizaka M.K., Zaman M.A., Calhoun D.A. Efficacy of low-dose spironolactone in subjects with resistant hypertension. Am J Hypertens 2003, 16:925-930.
80. Nussberger, J. (2000). Circulating versus tissue angiotensin II. Angiotensin II receptor antagonists. In: Epstein, M. and Brunner, H. (eds), Angiotensin II receptor antagonists. Hanley and Belfus Inc., Philadelphia, PA.
81. Oliver J.A., Sciacca R.R. Local generation of angiotensin II as a mechanism of regulation of peripheral vascular tone in the rat. J Clin Invest 1984, 74:1247-1251.
82. Paul M., Wagner J., Dzau V.J. Gene expression of the renin-angiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J Clin Invest 1993, 91:2058-2064.
83. Peach M.J. Renin-angiotensin system: biochemistry and mechanisms of action. Physiol Rev 1977, 57:313-370.
84. Pearce P., Funder J.W. High affinity aldosterone binding sites (type I receptors) in rat heart. Clin Exp Pharmacol Physiol 1987, 14:859-866.
85. Peti-Peterdi J., Warnock D.G., Bell P.D. Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. J Am Soc Nephrol 2002, 13:1131-1135.
86. Ploth D.W. Angiotensin-dependent renal mechanisms in two-kidney, one-clip renal vascular hypertension. Am J Physiol 1983, 245:F131-F141.
87. Pounarat J. The luminal membrane of rat limb expresses AT1 receptor and aminopeptidase activities. Kidney Int 2002, 62:434-445.
88. Prescott G., Silversides D.W., Chiu S.M., Reudelhuber T.L. Contribution of circulating renin to local synthesis of angiotensin peptides in the heart. Physiol Genomics 2000, 4:67-73.
89. Prescott G., Silversides D.W., Reudelhuber T.L. Tissue activity of circulating prorenin. Am J Hypertens 2002, 15:280-285.
90. Prieto-Carrasquero M.C., Kobori H., Ozawa Y., Gutierrez A., Seth D., Navar L.G. AT1 receptor-mediated enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Am J Physiol Renal Physiol 2005, 289:F632-F637.
91. Prieto-Carrasquero M.C., Harrison-Bernard L.M., Kobori H., et al. Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension 2004, 44:223-229.
92. Printz, M.P., Unger, T., and Phillips, M.I. (2003). The brain renin-angiotensin system. In: Ganten, D., Printz, M.P., Phillips, M.I. and Sholkens, B.A. (eds). The renin-angiotensin system in the brain: a model for synthesis of peptides in the brain. Springer-Verlag, Berlin.
93. Re R.N. Intracellular renin and the nature of intracrine enzymes. Hypertension 2003, 42:117-122.
94. Re R.N. Mechanisms of disease: local renin-angiotensin-aldosterone systems and the pathogenesis and treatment of cardiovascular disease. Nat Clin Pract Cardiovasc Med 2004, 1:42-47.
95. Re R.N. Tissue renin angiotensin systems. Med Clin North Am 2004, 88:19-38.
96. Re R.N., Cook J.L. The intracrine hypothesis: An update. Regul Pept 2006, 1-9.
97. Reaux A., Fournie-Zaluski M.C., David C., et al. Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc Natl Acad Sci USA 1999, 96:13415-13420.
98. Reaux-Le Goazigo A., Iturrioz X., Fassot C., Claperon C., Roques B.P., Llorens-Cortes C. Role of angiotensin III in hypertension. Curr Hypertens Rep 2005, 7:128-134.
99. Rocha R., Stier C.T., Kifor I., et al. Aldosterone: a mediator of myocardial necrosis and renal arteriopathy. Endocrinology 2000, 141:3871-3878.
100. Rocha R., Rudolph A.E., Frierdich G.E., et al. Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 2002, 283:H1802-H1810.
101. Rocha R., Chander P.N., Zuckerman A., Stier C.T. Role of aldosterone in renal vascular injury in stroke-prone hypertensive rats. Hypertension 1999, 33:232-237.
102. Rocha R., Chander P.N., Khanna K., Zuckerman A., Stier C.T. Mineralocorticoid blockade reduces vascular injury in stroke-prone hypertensive rats. Hypertension 1998, 31:451-458.
103. Rohrwasser A., Morgan T., Dillon H.F., et al. Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension 1999, 34:1265-1274.
104. Rossi G., Boscaro M., Ronconi V., Funder J.W. Aldosterone as a cardiovascular risk factor. Trends Endocrinol Metab 2005, 16:104-107.
105. Rousseau G., Baxter J.D., Funder J.W., Edelman I.S., Tomkins G.M. Glucocorticoid and mineralocorticoid receptors for aldosterone. J Steroid Biochem 1972, 3:219-227.
106. Saccomani G. Angiotensin II stimulation of Na(+)-H+ exchange in proximal tubule cells. Am J Phynol Renal Physiol 1990, 258:F1188-F1193.
107. Sadjadi J., Puttaparthi K., Welborn M.B., et al. Upregulation of autocrine-paracrine renin-angiotensin systems in chronic renovascular hypertension. J Vasc Surg 2002, 36:386-392.
108. Sakai K., Sigmund C.D. Molecular evidence of tissue renin-angiotensin systems: a focus on the brain. Curr Hypertens Rep 2005, 7:135-140.
109. Samani N.J., Swales J.D., Brammar W.J. Expression of the renin gene in extra-renal tissues of the rat. Biochem J 1988, 253:907-910.
110. Santos R.A., Simoes e Silva A.C., Maric C., et al. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 2003, 100:8258-8263.
111. Saris J.J., Derkx F.H., Lamers J.M., Saxena P.R., Schalekamp M.A., Danser A.H. Cardiomyocytes bind and activate native human prorenin: role of soluble mannose 6-phosphate receptors. Hypertension 2001, 37:710-715.
112. Sasaki K., Yamano Y., Bardhan S., et al. Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin II type-1 receptor. Nature 1991, 351:230-233.
113. Schiavone M.T., Santos R.A., Brosnihan K.B., Khosla M.C., Ferrario C.M. Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide. Proc Natl Acad Sci USA 1988, 85:4095-4098.
114. Schmitz U. Angiotensin II signal transduction; stimulation of multiple mitogen-active protein kinase pathways. Trends Endocrinol Metab 1997, 8:261-266.
115. Schmitz U., Thommes K., Beier I., et al. Angiotensin II-induced stimulation of p21-activated kinase and c-Jun NH2-terminal kinase is mediated by Rac1 and Nck. J Biol Chem 2001, 276:22003-22010.
116. Sealey J.E., White R.P., Laragh J.H., Rubin A.L. Plasma prorenin and renin in anephric patients. Circ Res 1977, 41:17-21.
117. Silvestre J.S., Robert V., Heymes C., et al. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation. J Biol Chem 1998, 273:4883-4891.
118. Siragy H.M., Carey R.M. Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension 1999, 33:1237-1242.
119. Siragy H.M., Xue C., Abadir P., Carey R.M. Angiotensin subtype-2 receptors inhibit renin biosynthesis and angiotensin II formation. Hypertension 2005, 45:133-137.
120. Siragy H.M., Howell N.L., Ragsdale N.V., Carey R.M. Renal interstitial fluid angiotensin. Modulation by anesthesia, epinephrine, sodium depletion, and renin inhibition. Hypertension 1995, 25:1021-1024.
121. Soubrier F., Wei L., Hubert C., Clauser E., Alhenc-Gelas F., Corvol P. Molecular biology of the angiotensin I converting enzyme: II. Structure-function. Gene polymorphism and clinical implications. J Hypertens 1993, 11:599-604.
122. Takeda Y. Vascular synthesis of aldosterone: role in hypertension. Mol Cell Endocrinol 2004, 217:75-79.
123. Takeda Y., Miyamori I., Inaba S., et al. Vascular aldosterone in genetically hypertensive rats. Hypertension 1997, 29:45-48.
124. Telmisartan, ramipril or both in patients at high risk for vascular events. N Engl J Med 2008, 358:1547-1559. The ONTARGET Investigators.
125. Thurston H., Swales J.D. Blood pressure response of nephrectomized hypertensive rats to converting enzyme inhibition: evidence for persistent vascular renin activity. Clin Sci Mol Med 1977, 52:299-304.
126. Tipnis S.R., Hooper N.M., Hyde R., Karran E., Christie G., Turner A.J. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 2000, 275:3323.
127. Tokuyama H., Hayashi K., Matsuda H., et al. Differential regulation of elevated renal angiotensin II in chronic renal ischemia. Hypertension 2002, 40:34-40.
128. Tschope C., Schultheiss H.P., Walther T. Multiple interactions between the renin-angiotensin and the kallikrein-kinin systems: role of ACE inhibition and AT1 receptor blockade. J Cardiovasc Pharmacol 2002, 39:478-487.
129. van den Eijnden M.M., Saris J.J., de Bruin R.J., et al. Prorenin accumulation and activation in human endothelial cells: importance of mannose 6-phosphate receptors. Arterioscler Thromb Vasc Biol 2001, 21:911-916.
130. van Kats J.P., Danser A.H., van Meegen J.R., Sassen L.M., Verdouw P.D., Schalekamp M.A. Angiotensin production by the heart: a quantitative study in pigs with the use of radiolabeled angiotensin infusions. Circulation 1998, 98:73-81.
131. van Kats J.P., Schalekamp M.A., Verdouw P.D., Duncker D.J., Danser A.H. Intrarenal angiotensin II: interstitial and cellular levels and site of production. Kidney Int 2001, 60:2311-2317.
132. van Kats J.P., Duncker D.J., Haitsma D.B., et al. Angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade prevent cardiac remodeling in pigs after myocardial infarction: role of tissue angiotensin II. Circulation 2000, 102:1556-1563.
133. Vicaut E., Hou X. Local renin-angiotensin system in the microcirculation of spontaneously hypertensive rats. Hypertension 1994, 24:70-76.
134. Virdis A., Neves M.F., Amiri F., Viel E., Touyz R.M., Schiffrin E.L. Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 2002, 40:504-510.
135. von Lutterotti N., Catanzaro D.F., Sealey J.E., Laragh J.H. Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation 1994, 89:458-470.
136. Wang C.T., Chin S.Y., Navar L.G. Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats. Am J Physiol Renal Physiol 2000, 279:F319-F325.
137. Watt G.C., Harrap S.B., Foy C.J., et al. Abnormalities of glucocorticoid metabolism and the renin-angiotensin system: a four-corners approach to the identification of genetic determinants of blood pressure. J Hypertens 1992, 10:473-482.
138. Weber, K., Sun, Y. and Guarda, E. (1995). Nonclassical actions of angiotensin II and aldosterone in non-classic target tissue (the heart): relevance to hypertensive heart disease. In Hypertension: pathophysiology, diagnosis, 2nd edn. 2203-2223.
139. Wolf G. The renin-angiotensin system and progression of renal diseases. Nephron Physiol. Lippincott, Williams and Wilkins, Philadelphia, PA 2003, P3-P13.
140. Wolf G., Wenzel U., Burns K.D., Harris R.C., Stahl R.A., Thaiss F. Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors. Kidney Int 2002, 61:1986-1995.
141. Wright J.W., Tamura-Myers E., Wilson W.L., et al. Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats. Am J Physiol Regul Integr Comp Physiol 2003, 284:R725-R733.
142. Xue C., Siragy H.M. Local renal aldosterone system and its regulation by salt, diabetes, and angiotensin II type 1 receptor. Hypertension 2005, 46:584-590.
143. Ye P., Kenyon C.J., MacKenzie S.M., et al. The aldosterone synthase (CYP11B2) and 11beta-hydroxylase (CYP11B1) genes are not expressed in the rat heart. Endocrinology 2005, 146:5287-5293.
144. Zhuo J.L., Imig J.D., Hammond T.G., Orengo S., Benes E., Navar L.G. Ang II accumulation in rat renal endosomes during Ang II-induced hypertension: role of AT(1) receptor. Hypertension 2002, 39:116-121.
145. Baker K.M., Chernin M.I., Schreiber T., et al. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regul Pept 2004, 120:5-13.
146. Balcells E., Meng Q.C., Johnson W.H., Oparil S., Dell'Italia L.J. Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations. Am J Physiol 1997, 273:H1769-H1774.
147. Danser A.H., van Kesteren C.A., Bax W.A., et al. Prorenin, rennin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding. Circulation 1997, 96:220-226.
148. Dell'Italia L.J., Meng Q.C., Balcells E., et al. Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces. J Clin Invest 1997, 100:253-258.
149. Mazzolai L., Nussberger J., Aubert J.F., et al. Blood pressure-independent cardiac hypertrophy induced by locally activated renin-angiotensin system. Hypertension 1998, 31:1324-1330.
150. Neri Serneri G.G., Boddi M., Coppo M., et al. Evidence for the existence of a functional cardiac renin-angiotensin system in humans. Circulation 1996, 94:1886-1893.
151. Peters J., Farrenkopf R., Clausmeyer S., et al. Functional significance of prorenin internalization in the rat heart. Circ Res 2002, 90:1135-1141.
152. Sinn P.L., Sigmund C.D. Identification of three human renin mRNA isoforms from alternative tissue-specific transcriptional initiation. Physiol Genomics 2000, 3:25-31.
153. Urata H., Boehm K.D., Philip A., et al. Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 1993, 91:1269-1281.